APA

Zhao J., Liu S., Gao D., Ding S., Niu Z., Zhang H., Huang Z., Qiu J., Li Q., Li N., Xie F., Cui J. & Lu J. (20180220). Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA. : Oncotarget.

Chicago

Zhao Jing, Liu Shuai, Gao Dexuan, Ding Sentai, Niu Zhihong, Zhang Hui, Huang Zhilong, Qiu Juhui, Li Qing, Li Ning, Xie Fang, Cui Jilei and Lu Jiaju. 20180220. Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA. : Oncotarget.

Harvard

Zhao J., Liu S., Gao D., Ding S., Niu Z., Zhang H., Huang Z., Qiu J., Li Q., Li N., Xie F., Cui J. and Lu J. (20180220). Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA. : Oncotarget.

MLA

Zhao Jing, Liu Shuai, Gao Dexuan, Ding Sentai, Niu Zhihong, Zhang Hui, Huang Zhilong, Qiu Juhui, Li Qing, Li Ning, Xie Fang, Cui Jilei and Lu Jiaju. Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA. : Oncotarget. 20180220.